Lisa Speigl
Tuebingen, BW 72072, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells in Vitro and in Situ but are also Present in Benign Differentiated Cells.
Journal: Frontiers in bioscience (Landmark edition)
Published: May 17, 2023
Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
Journal: Clinical breast cancer
Published: January 08, 2019
Inhibiting HSP90 prevents the induction of myeloid-derived suppressor cells by melanoma cells.
Journal: Cellular immunology
Published: January 09, 2018
CD14+ HLA-DR-/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation.
Journal: Breast cancer research and treatment
Published: August 23, 2017
Low levels of intra-tumoural T cells in breast cancer identify clinically frail patients with shorter disease-specific survival.
Journal: Journal of geriatric oncology
Published: May 25, 2017
Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.
Journal: The British journal of dermatology
Published: November 22, 2016
Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients.
Journal: Breast cancer research and treatment
Published: September 01, 2016
A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.
Journal: Cellular and molecular life sciences : CMLS
Published: February 04, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026